Abstract:Background: Bidirectional interaction between gut and brain is associated with the maintenance of host nervous system health. Considerable progress has been made in understanding how microbiota-related gut signals affect central nervous system, however, how nervous diseases leading to dysbiosis is not well recognized. Method: We investigated changes in gut microbiota in a depression model induced by chronic unpredicted mild stress (CUMS) and a restoration model by applying the classic antidepressant drug fluoxetine. Behavior tests were performed to evaluate the depression and anxiety-like behaviors, 16S rRNA amplicon sequencing was used to analyze the gut microbiota profiles. Findings: In CUMS-induced depression model, fluoxetine showed significant antidepressant and mild anti-anxiety effects in mice. Consistent with behavior test, in gut microbiota, CUMS led to low bacterial diversity, simpler bacterial network, and altered microbiota. Most intriguingly, CUMS led to increased abundance of pathogens, such as Escherichia/Shigella, and conditional pathogens, such as Enterococcus, Vagococcus, and Aerococcus. However, these changes were attenuated by fluoxetine directly and indirectly. Furthermore, correlations analysis indicated strong correlations between gut microbiota and anxiety- and depression-like behaviors. Interpretation: This study reveals that fluoxetine leads to restoration of dysbiosis induced by stress stimulation. It suggests that antidepressant effects of fluoxetine in CUMS model may be mediated, in part, by the restoration of the gut microbiota. Altogether, our finding uncover a novel role of nervous disorders on gut microbiota. Funding Statement: This study was supported by the National Natural Science Foundation of China (grant No. 81730016). Declaration of Interests: The authors have no conflicts of interest to declare. Ethics Approval Statement: All procedures carried out in accordance with the recommendations of 'the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.' The protocol was approved by the Animal Research Ethics Board of The Fourth Military Medical University (Approval number: 20170206).

Mir-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats.

Effects of Fluoxetine on gut Microbiota in Chronic Unpredictable Stress-Induced Depressive-Like Rats

The influence of fluoxetine on plasma miR-34a, miR-134 and miR-143 expression of CUMS model rats

The Role of Microbiota Remodeling in the Antidepressant Effects of Fluoxetine

Mir-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus

Antidepressant Drugs Correct the Imbalance Between Probdnf/p75ntr/sortilin and Mature BDNF/TrkB in the Brain of Mice with Chronic Stress

Involvement of Mtor‐related Signaling in Antidepressant Effects of Sophoraflavanone G on Chronically Stressed Mice

Involvement of Chronic Unpredictable Mild Stress-Induced Hippocampal LRP1 Up-Regulation in Microtubule Instability and Depressive-Like Behavior in a Depressive-Like Adult Male Rat Model.

MiR-184-3p in the paraventricular nucleus participates in the neurobiology of depression via regulation of the hypothalamus-pituitary-adrenal axis

miR-29a-5p rescues depressive-like behaviors in a CUMS-induced mouse model by facilitating microglia M2-polarization in the prefrontal cortex via TMEM33 suppression

Quercetin attenuates brain apoptosis in mice with chronic unpredictable mild stress-induced depression

Metoprolol, N-Acetylcysteine, and Escitalopram Prevents Chronic Unpredictable Mild Stress-Induced Depression by Inhibition of Endoplasmic Reticulum Stress

Resveratrol Exerts Antidepressant Properties in the Chronic Unpredictable Mild Stress Model Through the Regulation of Oxidative Stress and Mtor Pathway in the Rat Hippocampus and Prefrontal Cortex.

Differential Regulation of Neurotrophic Factor and It Receptor Mrna and Protein by Chronic Fluoxetine and Stress in the Adult Rat Hippocampus and Amygdaloid Nuclei

Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor

Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice

Comparison of Therapeutic Effects of TREK1 Blockers and Fluoxetine on Chronic Unpredicted Mild Stress Sensitive Rats.

Chronic Fluoxetine Treatment Reverses Depressive-like Behaviors in Mice via Enhancing Neuroplasticity

Probiotics Alleviate Depressive Behavior in Chronic Unpredictable Mild Stress Rat Models by Remodeling Intestinal Flora.

Changes in white matter and the effects of fluoxetine on such changes in the CUS rat model of depression

miR-204-5p plays a critical role in the pathogenesis of depression and anti-depression action of Venlafaxine in the hippocampus of mice